Ligand source activities (1 row/activity)
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
72943279 | 185533 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 425 | 3 | 2 | 4 | 5.5 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C)cc(C)c4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4861425 | 185533 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 425 | 3 | 2 | 4 | 5.5 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C)cc(C)c4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164624123 | 185861 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 415 | 3 | 2 | 4 | 5.0 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4866325 | 185861 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 415 | 3 | 2 | 4 | 5.0 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164623072 | 186281 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 411 | 3 | 2 | 4 | 5.1 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4872591 | 186281 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 411 | 3 | 2 | 4 | 5.1 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164610567 | 184779 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 465 | 3 | 2 | 4 | 5.9 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4849848 | 184779 | None | 0 | Human | Functional | pEC50 | = | 10.9 | 10.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 465 | 3 | 2 | 4 | 5.9 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164614320 | 185492 | None | 0 | Human | Functional | pEC50 | = | 10.8 | 10.8 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(Cl)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4860633 | 185492 | None | 0 | Human | Functional | pEC50 | = | 10.8 | 10.8 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(Cl)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
118057812 | 186326 | None | 0 | Human | Functional | pEC50 | = | 10.8 | 10.8 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 431 | 4 | 2 | 5 | 4.7 | COc1cc(F)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4873269 | 186326 | None | 0 | Human | Functional | pEC50 | = | 10.8 | 10.8 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 431 | 4 | 2 | 5 | 4.7 | COc1cc(F)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
118057816 | 185018 | None | 0 | Human | Functional | pEC50 | = | 10.7 | 10.7 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 419 | 3 | 2 | 4 | 4.8 | Cc1cc(F)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4853282 | 185018 | None | 0 | Human | Functional | pEC50 | = | 10.7 | 10.7 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 419 | 3 | 2 | 4 | 4.8 | Cc1cc(F)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164615920 | 185381 | None | 0 | Human | Functional | pEC50 | = | 10.6 | 10.6 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 422 | 3 | 2 | 5 | 4.7 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C#N)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4858892 | 185381 | None | 0 | Human | Functional | pEC50 | = | 10.6 | 10.6 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 422 | 3 | 2 | 5 | 4.7 | Cc1cc(C)cc(-c2cncc(-c3nc4cc(C#N)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
2055 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
383414 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
448601 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
448601.0 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
90488715 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
CHEMBL1680 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
CHEMBL262746 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
DB00104 | 2907 | None | 39 | Human | Functional | pEC50 | = | 10.5 | 10.5 | 8 | 5 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | None | None | None | None | 10.1016/j.bmc.2021.116424 | ||||
72943278 | 185710 | None | 0 | Human | Functional | pEC50 | = | 10.5 | 10.5 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 428 | 4 | 2 | 4 | 5.2 | Cc1cc(C)cc(NC(=O)c2cncc(-c3cc(C)cc(C)c3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4863880 | 185710 | None | 0 | Human | Functional | pEC50 | = | 10.5 | 10.5 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 428 | 4 | 2 | 4 | 5.2 | Cc1cc(C)cc(NC(=O)c2cncc(-c3cc(C)cc(C)c3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
118057665 | 184507 | None | 0 | Human | Functional | pEC50 | = | 10.4 | 10.4 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 428 | 4 | 2 | 4 | 5.2 | Cc1cc(C)cc(C(=O)Nc2cncc(-c3cc(C)cc(C)c3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4845867 | 184507 | None | 0 | Human | Functional | pEC50 | = | 10.4 | 10.4 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 428 | 4 | 2 | 4 | 5.2 | Cc1cc(C)cc(C(=O)Nc2cncc(-c3cc(C)cc(C)c3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164624692 | 186152 | None | 0 | Human | Functional | pEC50 | = | 10.4 | 10.4 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 458 | 4 | 2 | 6 | 4.3 | Cc1cc(C(=O)Nc2cncc(-c3cc(Cl)cc(Cl)c3)c2N2CCC(N)CC2)n(C)n1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4870834 | 186152 | None | 0 | Human | Functional | pEC50 | = | 10.4 | 10.4 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 458 | 4 | 2 | 6 | 4.3 | Cc1cc(C(=O)Nc2cncc(-c3cc(Cl)cc(Cl)c3)c2N2CCC(N)CC2)n(C)n1 | 10.1016/j.bmc.2021.116424 | ||
164622117 | 185590 | None | 0 | Human | Functional | pEC50 | = | 10.3 | 10.3 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 443 | 5 | 2 | 6 | 4.5 | COc1cc(OC)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4862195 | 185590 | None | 0 | Human | Functional | pEC50 | = | 10.3 | 10.3 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 443 | 5 | 2 | 6 | 4.5 | COc1cc(OC)cc(-c2cncc(-c3nc4cc(C)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
118057675 | 186534 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 435 | 4 | 2 | 5 | 4.5 | COc1cc(F)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4876263 | 186534 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 435 | 4 | 2 | 5 | 4.5 | COc1cc(F)cc(-c2cncc(-c3nc4cc(F)ccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
118057538 | 184932 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 397 | 3 | 2 | 4 | 4.8 | Cc1cc(C)cc(-c2cncc(-c3nc4ccccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4851978 | 184932 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 397 | 3 | 2 | 4 | 4.8 | Cc1cc(C)cc(-c2cncc(-c3nc4ccccc4[nH]3)c2N2CCC(N)CC2)c1 | 10.1016/j.bmc.2021.116424 | ||
164627529 | 186713 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 439 | 3 | 2 | 4 | 5.2 | NC1CCN(c2c(-c3cc(F)cc(Cl)c3)cncc2-c2nc3cc(F)ccc3[nH]2)CC1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4878917 | 186713 | None | 0 | Human | Functional | pEC50 | = | 10.1 | 10.1 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 439 | 3 | 2 | 4 | 5.2 | NC1CCN(c2c(-c3cc(F)cc(Cl)c3)cncc2-c2nc3cc(F)ccc3[nH]2)CC1 | 10.1016/j.bmc.2021.116424 | ||
164614581 | 185107 | None | 0 | Human | Functional | pEC50 | = | 10 | 10.0 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 512 | 4 | 2 | 6 | 5.0 | Cn1ncc(C(=O)Nc2cncc(-c3cc(Cl)cc(Cl)c3)c2N2CCC(N)CC2)c1C(F)(F)F | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4854548 | 185107 | None | 0 | Human | Functional | pEC50 | = | 10 | 10.0 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 512 | 4 | 2 | 6 | 5.0 | Cn1ncc(C(=O)Nc2cncc(-c3cc(Cl)cc(Cl)c3)c2N2CCC(N)CC2)c1C(F)(F)F | 10.1016/j.bmc.2021.116424 | ||
16129706 | 211490 | None | 36 | Human | Functional | pEC50 | = | 10 | 10.0 | -4 | 12 | Inhibition of forskolin-induced cAMP accumulation in CHO-K1 cells expressing human sst2 receptorInhibition of forskolin-induced cAMP accumulation in CHO-K1 cells expressing human sst2 receptor |
ChEMBL | None | None | None | C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O | 10.1016/j.bmcl.2005.05.061 | ||||
CHEMBL1823872 | 211490 | None | 36 | Human | Functional | pEC50 | = | 10 | 10.0 | -4 | 12 | Inhibition of forskolin-induced cAMP accumulation in CHO-K1 cells expressing human sst2 receptorInhibition of forskolin-induced cAMP accumulation in CHO-K1 cells expressing human sst2 receptor |
ChEMBL | None | None | None | C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O | 10.1016/j.bmcl.2005.05.061 | ||||
162666722 | 182352 | None | 0 | Human | Functional | pEC50 | = | 10.0 | 10.0 | -2 | 2 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)CC2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4783565 | 182352 | None | 0 | Human | Functional | pEC50 | = | 10.0 | 10.0 | -2 | 2 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)CC2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
140762567 | 180383 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | 64 | 3 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4750691 | 180383 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | 64 | 3 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
164624443 | 185611 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 458 | 4 | 2 | 6 | 4.3 | Cc1nn(C)cc1C(=O)Nc1cncc(-c2cc(Cl)cc(Cl)c2)c1N1CCC(N)CC1 | 10.1016/j.bmc.2021.116424 | ||
CHEMBL4862497 | 185611 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | - | 1 | Agonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP AssayAgonist activity at human SSTR2 expressed in CHO-K1 cells assessed as inhibition of forskolin-induced cAMP accumulation measured after 30 mins by GloSensor cAMP Assay |
ChEMBL | 458 | 4 | 2 | 6 | 4.3 | Cc1nn(C)cc1C(=O)Nc1cncc(-c2cc(Cl)cc(Cl)c2)c1N1CCC(N)CC1 | 10.1016/j.bmc.2021.116424 | ||
140762567 | 180383 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | 64 | 3 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4750691 | 180383 | None | 0 | Human | Functional | pEC50 | = | 9.9 | 9.9 | 64 | 3 | Agonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulationAgonist activity at human SST2 expressed in CHO-K1 cells assessed as reduction in NKH477-induced intracellular cAMP accumulation |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 |
Showing 1 to 50 of 452 entries
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
171347244 | 194435 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 468 | 4 | 2 | 6 | 5.2 | COc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5286005 | 194435 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 468 | 4 | 2 | 6 | 5.2 | COc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
140762567 | 180383 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4750691 | 180383 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)cc(F)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
171347244 | 194435 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 468 | 4 | 2 | 6 | 5.2 | COc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5286005 | 194435 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 468 | 4 | 2 | 6 | 5.2 | COc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
171352686 | 194129 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 458 | 4 | 2 | 4 | 4.9 | NC(=O)c1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5279239 | 194129 | None | 0 | Human | Binding | pEC50 | = | 9.9 | 9.9 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 458 | 4 | 2 | 4 | 4.9 | NC(=O)c1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
140762568 | 181370 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 547 | 6 | 2 | 5 | 5.3 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(F)cc(C(N)=O)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4761949 | 181370 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 547 | 6 | 2 | 5 | 5.3 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(F)cc(C(N)=O)c4)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
171352686 | 194129 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 458 | 4 | 2 | 4 | 4.9 | NC(=O)c1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5279239 | 194129 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 458 | 4 | 2 | 4 | 4.9 | NC(=O)c1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
171357026 | 194155 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 449 | 3 | 2 | 4 | 5.6 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(F)c4O)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5279994 | 194155 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 449 | 3 | 2 | 4 | 5.6 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(F)c4O)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
171349150 | 194317 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(O)c4)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5283444 | 194317 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(O)c4)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
140837181 | 194468 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 452 | 3 | 2 | 5 | 5.5 | Cc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5286879 | 194468 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 452 | 3 | 2 | 5 | 5.5 | Cc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
171349150 | 194317 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(O)c4)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5283444 | 194317 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 431 | 3 | 2 | 4 | 5.5 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(O)c4)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
171357026 | 194155 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 449 | 3 | 2 | 4 | 5.6 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(F)c4O)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5279994 | 194155 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 449 | 3 | 2 | 4 | 5.6 | NC1CCN(c2c(-c3cc(F)cc(F)c3)cnc3ccc(-c4cccc(F)c4O)cc23)CC1 | 10.1021/acsmedchemlett.2c00431 | ||
140837181 | 194468 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 452 | 3 | 2 | 5 | 5.5 | Cc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5286879 | 194468 | None | 0 | Human | Binding | pEC50 | = | 9.8 | 9.8 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 452 | 3 | 2 | 5 | 5.5 | Cc1cc(F)cc(-c2cnc3ccc(-c4cccc(C#N)c4O)cc3c2N2CCC(N)CC2)c1 | 10.1021/acsmedchemlett.2c00431 | ||
140762573 | 182483 | None | 0 | Human | Binding | pEC50 | = | 9.7 | 9.7 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)ccc4F)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4785112 | 182483 | None | 0 | Human | Binding | pEC50 | = | 9.7 | 9.7 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cc(O)ccc4F)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
134168328 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
134168328.0 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL4594359 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5267842 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
134168328 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
134168328.0 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL4594359 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5267842 | 193648 | None | 22 | Human | Binding | pEC50 | = | 9.6 | 9.6 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 456 | 3 | 2 | 5 | 5.4 | N#Cc1cccc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
166992296 | 193855 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 438 | 3 | 2 | 5 | 5.2 | N#Cc1cccc(-c2ccc3ncc(-c4cccc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5273084 | 193855 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 438 | 3 | 2 | 5 | 5.2 | N#Cc1cccc(-c2ccc3ncc(-c4cccc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
166992296 | 193855 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 438 | 3 | 2 | 5 | 5.2 | N#Cc1cccc(-c2ccc3ncc(-c4cccc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5273084 | 193855 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 438 | 3 | 2 | 5 | 5.2 | N#Cc1cccc(-c2ccc3ncc(-c4cccc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
140836905 | 194015 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 474 | 3 | 2 | 5 | 5.5 | N#Cc1cc(F)cc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5276605 | 194015 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 474 | 3 | 2 | 5 | 5.5 | N#Cc1cc(F)cc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
140836905 | 194015 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 474 | 3 | 2 | 5 | 5.5 | N#Cc1cc(F)cc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
CHEMBL5276605 | 194015 | None | 0 | Human | Binding | pEC50 | = | 9.5 | 9.5 | - | 0 | Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assayAgonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay |
ChEMBL | 474 | 3 | 2 | 5 | 5.5 | N#Cc1cc(F)cc(-c2ccc3ncc(-c4cc(F)cc(F)c4)c(N4CCC(N)CC4)c3c2)c1O | 10.1021/acsmedchemlett.2c00431 | ||
162666722 | 182352 | None | 0 | Rat | Binding | pEC50 | = | 9.3 | 9.3 | - | 0 | Agonist activity at rat SST2Agonist activity at rat SST2 |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)CC2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4783565 | 182352 | None | 0 | Rat | Binding | pEC50 | = | 9.3 | 9.3 | - | 0 | Agonist activity at rat SST2Agonist activity at rat SST2 |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)CC2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
162648021 | 180079 | None | 0 | Human | Binding | pEC50 | = | 9.1 | 9.1 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
CHEMBL4746816 | 180079 | None | 0 | Human | Binding | pEC50 | = | 9.1 | 9.1 | - | 0 | Agonist activity at SST2 (unknown origin)Agonist activity at SST2 (unknown origin) |
ChEMBL | 520 | 5 | 2 | 5 | 5.9 | Cc1cc(Cl)cc(N2C=Nc3cc(C)c(-c4cccc(F)c4O)cc3C2C(=O)N(C)C[C@@H]2CCCN2)c1 | 10.1016/j.bmcl.2020.127391 | ||
155544425 | 173486 | None | 0 | Human | Binding | pEC50 | = | 9 | 9.0 | 436 | 5 | Binding affinity to human SSTR2 expressed in CHO-K1 cells assessed as induction of SSTR2 internalization after 4 hrs by chemiluminescent assayBinding affinity to human SSTR2 expressed in CHO-K1 cells assessed as induction of SSTR2 internalization after 4 hrs by chemiluminescent assay |
ChEMBL | 1785 | 27 | 15 | 26 | 3.3 | COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O)[C@@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2 | 10.1021/acs.jmedchem.8b02036 | ||
CHEMBL4527856 | 173486 | None | 0 | Human | Binding | pEC50 | = | 9 | 9.0 | 436 | 5 | Binding affinity to human SSTR2 expressed in CHO-K1 cells assessed as induction of SSTR2 internalization after 4 hrs by chemiluminescent assayBinding affinity to human SSTR2 expressed in CHO-K1 cells assessed as induction of SSTR2 internalization after 4 hrs by chemiluminescent assay |
ChEMBL | 1785 | 27 | 15 | 26 | 3.3 | COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O)[C@@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\C)C2 | 10.1021/acs.jmedchem.8b02036 | ||
118753685 | 120683 | None | 0 | Human | Binding | pEC50 | = | 9 | 9.0 | - | 0 | Relative effective concentration against human somatostatin receptor type 2 expressed in CHO cells; (n=3)Relative effective concentration against human somatostatin receptor type 2 expressed in CHO cells; (n=3) |
ChEMBL | 1160 | 17 | 14 | 15 | -0.5 | C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 | 10.1021/jm040794i | ||
CHEMBL3144288 | 120683 | None | 0 | Human | Binding | pEC50 | = | 9 | 9.0 | - | 0 | Relative effective concentration against human somatostatin receptor type 2 expressed in CHO cells; (n=3)Relative effective concentration against human somatostatin receptor type 2 expressed in CHO cells; (n=3) |
ChEMBL | 1160 | 17 | 14 | 15 | -0.5 | C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 | 10.1021/jm040794i |
Showing 1 to 50 of 2,448 entries